Lynn E. Bayless
General Counsel chez MUSTANG BIO, INC.
Profil
Lynn E.
Bayless is a professional with experience in regulatory affairs.
Currently, Bayless is the Head of Regulatory Affairs at Mustang Bio, Inc. Prior to this, Bayless held the position of Senior Director of Regulatory Affairs at Nightstar Therapeutics Ltd.
from 2018 to 2020.
From 2015 to 2018, Bayless worked as the Director of Regulatory Affairs at Voyager Therapeutics, Inc. Bayless has an undergraduate degree from Quinnipiac University and a graduate degree from Massachusetts College of Pharmacy & Health Science.
Postes actifs de Lynn E. Bayless
| Sociétés | Poste | Début |
|---|---|---|
| MUSTANG BIO, INC. | General Counsel | 01/01/2020 |
Anciens postes connus de Lynn E. Bayless
| Sociétés | Poste | Fin |
|---|---|---|
| NIGHTSTAR THERAPEUTICS PLC | General Counsel | 01/02/2020 |
| VOYAGER THERAPEUTICS, INC. | General Counsel | 01/10/2018 |
Formation de Lynn E. Bayless
| Massachusetts College of Pharmacy & Health Science | Graduate Degree |
| Quinnipiac University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| VOYAGER THERAPEUTICS, INC. | Health Technology |
| MUSTANG BIO, INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Nightstar Therapeutics Ltd.
 Nightstar Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Nightstar Therapeutics Ltd. is a clinical-stage gene therapy. It engages in the development and commercialization of novel one-time treatments for patients suffering from rare inherited retinal diseases. The company was founded by Robert MacLaren, Miguel Seabra and Matthew During in 2014 and is headquartered in London, the United Kingdom. | Health Technology |
